The new venture could be engaged in the processing, development, marketing, wholesale and retail of pharmaceutical products promoting in the meanwhile the licensing of new products.
The general scope is the production and the development of the distribution channel of more effective products. The business plan includes research and development process, as follows:
- Preparation and designation of new products to all parts of the value chain of the health sector.
- Research and development of the research & the information'' platform'', initially in a test environment and then for marketing.
- Original testing procedures.
- Managing and coordinating administrative and supporting the overall project level.
- Setting up or modernization of infrastructure and supply facilities.
- Designation of marketing services.
- Developing the skills of sales staff and support.
- The development of the distribution channel.
The investment projects would be analyzed:
- Strategically:
- Asset initial invest such as land, building (location)
- Specialized Facilities (Clean Room)
- Machinery definition
- Vision
- Targets (ratios, modeling, benchmarking)
- HR policies
and
- operationally:
- Working capital requirements
- Functions (production lines, accounting, sales, deliveries, ict)
- Staff
- Products (segmentation policies, marketing etc)
- Life cycle
The process regarding the development of a model (BUSINESS SCORECARD MODEL) measurement and the evaluation of commercial products responsiveness would consist part of the business plan implementation and in particular:
- Measurement Model - Balanced Performance Scorecard, which will include pilots and indicators with quantitative and qualitative data, registration of new services.
- Benchmarking Analytics (performance measurement) for the interpretation and use of financial and qualitative results of the services
Machinery and equipment (production lines) would be procured either from Greece, EU or third Countries. CE certifications are necessary.
Qualified personnel would be shortlisted in order to be evaluated and hired.
At all cases hygiene and safety measures must be in compliance with the provisions of the current legislation without any exemptions.
The main strategic goals of the company, in the framework of the implementation of the business plan would be following:
- Sustainability of the R & D works.
- Distribution of innovative, mature and commercially available products.
- Strengthening the level of competitiveness, exploiting new technologies.
- Broaden the company portfolio (sales growth) regarding the niche market of health industry abroad.
- Utilization & exploitation of additional funding (EU) opportunities.